Variant report
Variant | nsv561952 |
---|---|
Chromosome Location | chr13:64259484-64290806 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-PCDH20-9 | chr13:64261535-64261688 | XLOC_010643 |
2 | lnc-PCDH20-9 | chr13:64288485-64288508 | XLOC_010643 |
No data |
No data |
Variant related genes | Relation type |
---|---|
DUSP2 | miRNA target sites |
DUSP3 | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs17088704 | chr13:64259484-64259485 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs76696476 | chr13:64259513-64259514 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs562050949 | chr13:64259526-64259527 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs376164010 | chr13:64259545-64259546 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs529453076 | chr13:64259566-64259567 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs547862435 | chr13:64259571-64259572 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs565873931 | chr13:64259594-64259595 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs539222518 | chr13:64259658-64259659 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs140230537 | chr13:64259696-64259697 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs12864820 | chr13:64259703-64259704 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs551674168 | chr13:64259764-64259765 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs9570989 | chr13:64259767-64259768 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs536932504 | chr13:64259786-64259787 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs532120253 | chr13:64261536-64261537 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
15 | rs550433051 | chr13:64261570-64261571 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
16 | rs568997710 | chr13:64261571-64261572 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
17 | rs144637604 | chr13:64261619-64261620 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
18 | rs549609083 | chr13:64261621-64261622 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
19 | rs567813181 | chr13:64261643-64261644 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
20 | rs9570993 | chr13:64261656-64261657 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
21 | rs181124499 | chr13:64261665-64261666 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
22 | rs115344933 | chr13:64261678-64261679 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs367965293 | chr13:64262804-64262805 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs76271555 | chr13:64262815-64262816 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs78912187 | chr13:64262834-64262835 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs17088713 | chr13:64262893-64262894 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs9570996 | chr13:64262939-64262940 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs547185114 | chr13:64262940-64262941 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs76150451 | chr13:64262945-64262946 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs9570997 | chr13:64262946-64262947 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs180861980 | chr13:64262982-64262983 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs543667892 | chr13:64262991-64262992 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs386771710 | chr13:64262999-64263000 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs568947488 | chr13:64263001-64263002 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs140249795 | chr13:64263009-64263010 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs150293076 | chr13:64263061-64263062 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs375488314 | chr13:64263075-64263076 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs533997621 | chr13:64263077-64263078 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs185911827 | chr13:64263106-64263107 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs145416774 | chr13:64263118-64263119 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs149211079 | chr13:64263236-64263237 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs143342747 | chr13:64263279-64263280 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs191234744 | chr13:64263322-64263323 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs183170281 | chr13:64263329-64263330 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs185628149 | chr13:64263342-64263343 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs9570998 | chr13:64263345-64263346 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs371999265 | chr13:64263379-64263380 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs571403957 | chr13:64263381-64263382 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs9570999 | chr13:64263419-64263420 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs565518922 | chr13:64263430-64263431 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Prostate cancer | 16573809 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 17245344 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21858162 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
abnormal development | 18461090 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:64259000-64259800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
2 | chr13:64259000-64259800 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
3 | chr13:64259200-64259600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
4 | chr13:64262800-64263600 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
5 | chr13:64274200-64275000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
6 | chr13:64274400-64274800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
7 | chr13:64274400-64275000 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
8 | chr13:64274600-64275200 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
9 | chr13:64279200-64279600 | Enhancers | Fetal Brain Male | brain |